Patient preferences for stroke prevention treatments in atrial fibrillation in Asia: A discrete choice experiment
Patients with atrial fibrillation were willing to accept an increased risk of non-disabling events in exchange for a reduced risk of death but had diverse preferences for treatment administration characteristics. These findings can inform patient-centered treatment strategies that consider the relative importance of treatment attributes in clinical decision-making.
Authors
- Tommi Tervonen (ORCID: https://orcid.org/0000-0001-7303-500X)
- Hiroshi Higashiyama
- Gabriela Fernandez
- Nicolas Krucien (ORCID: https://orcid.org/0000-0001-9179-6558)
- Juan Du (ORCID: https://orcid.org/0000-0003-2538-4007)
- Matthew Quaife (ORCID: https://orcid.org/0000-0001-9291-1511)
- Rosa Wang (ORCID: https://orcid.org/0000-0001-8109-4210)
- Xin Ye (ORCID: https://orcid.org/0000-0002-8429-0900)
- Hui Lu (ORCID: https://orcid.org/0000-0001-9631-0975)
- Dong Huang (ORCID: https://orcid.org/0000-0002-0935-5356)
Institutions
- Ithaka Harbors (US)
- Daiichi Sankyo (Germany) (DE)
- EVRAZ (United Kingdom) (GB)
- Shanghai Sixth People's Hospital (CN)
- Daiichi Sankyo (United States) (US)
Publication Details
- Journal
- Preventive Medicine Reports
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1016/j.pmedr.2025.103084
- Citations
- 1
- Primary Topic
- Economic and Environmental Valuation
- Type
- article
- Field-Weighted Citation Impact
- 3.13
Funders
- Daiichi-Sankyo
- Daiichi Sankyo Company